FindTrial
Sign In

Study to check the safety and efficacy of skin product on human

To evaluate the in vivo safety and efficacy of skin care formulation in terms of improvement in skin brightening, even tone and radiance, and reduction in spots on healthy human participants - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113364
Enrollment
30
Registered
2026-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: First Light Brightening Emulsion Serum: Product is applied on the whole face twice in a day at morning and night for the period of 45 days Control Intervention1: Nil: NA

Sponsors

Thirty Thirty Skincare Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian Male & Female participants 2)Healthy subjects 3)Skin is healthy on the studied anatomic unit 4)Having uneven skin tone with pigmentary spots (age spots)

Exclusion criteria

Exclusion criteria: 1)For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2)Having refused to give her assent by not signing the consent form. 3)Taking part in another study liable to interfere with this study. 4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months). 5)Having a progressive asthma. 6)Being epileptic. 7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months). 8)Having cutaneous hypersensitivity. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 9)Having consumed caffeine-based products (coffee, cola, tea ), alcohol, highly spiced foods and/or smoked in the two hours preceding the measurements. 10)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 11)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit 12)Having applied a cosmetic product (included make-up) or skin care product on the studied areas the day of the study (only face cleaned with water is accepted)

Design outcomes

Primary

MeasureTime frame
Skin brightening, even tone & radiance, & reduction in spotsTimepoint: Baseline, 15 Days, 45 Days—

Secondary

MeasureTime frame
NilTimepoint: NA—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in08657063276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026